BY ALLERGIC LIVING When the U.S. Food and Drug Administration (FDA) approved a new oral immunotherapy (OIT) for peanut allergy… Read more »
The manufacturer of the Viaskin Peanut patch has announced plans to resubmit its biologics license application (BLA) for the therapy… Read more »
Hundreds of allergists turned out to see Dr. Stacie Jones present highly anticipated study results at the AAAAI/WAO joint congress… Read more »
After six months of treatment, more than 80 percent of the children taking the therapy were able to eat at least five peanuts a day
A new pilot study has resulted in subjects being able to tolerate 160 to 400 times more peanut than they could at the study’s outset.